AIMNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
AIM ImmunoTech Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$0.16−0.01 (-2.97%)
Close on Oct 19, 2026
- Market cap
- $2.79M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Aug 14, 2025(first seen in filings) | 1-for-100 reverse | Earlier per-share figures multiplied by 100 |
| Jun 12, 2025 | 1-for-100 reverse | Earlier per-share figures multiplied by 100 |
| Aug 14, 2019(first seen in filings) | 1-for-44 reverse | Earlier per-share figures multiplied by 44 |
| Jun 11, 2019 | 1-for-44 reverse | Earlier per-share figures multiplied by 44 |
| Nov 14, 2016(first seen in filings) | 1-for-12 reverse | Earlier per-share figures multiplied by 12 |
| Aug 29, 2016 | 1-for-12 reverse | Earlier per-share figures multiplied by 12 |